Tivicay
NDC 49702-226, dolutegravir sodium, tablet, film coated, from ViiV Healthcare Company.
- Product NDC
- 49702-226
- Status
- Listed
- Labeler
- ViiV Healthcare Company
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA204790
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/49702-226 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DOLUTEGRAVIR SODIUM10 mg/1
Pharmacologic classes
HIV Integrase Inhibitors [MoA]; Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]; Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]; Organic Cation Transporter 2 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 49702-226-13 | 49702022613 | 30 TABLET, FILM COATED in 1 BOTTLE (49702-226-13) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/63df5af3-b8ac-4e76-9830-2dbb340af922
Use it
Look up 49702-226 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/49702-226 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 49702-226. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.